1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 15 FEBRUARY 2016

CNS Drug News 15 FEBRUARY 2016

  • February 2016
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Digital Healthcare Partnerships Offer Expedited Development Potential
Industry Brief - LCT Gains Ethics Approval For Ntcell Phase IIb Trial In PD
Industry Brief - Amarantus Receives FDA ODD For Eltoprazine In PD-LID
Industry Brief - Takeda/Zinfandel Complete Enrolment In Pioglitazone Phase III Trial In MCI Due To AD
Industry Brief - First Patient Dosed In Neurotrope's Phase IIb Trial Of Bryostatin In AD
Industry Trend Analysis - Generics Remain Essential For Teva As Copaxone Revenues Falter
Industry Trend Analysis - Expanded Label Will Increase Brintellix Commercial Viability
Industry Brief - Shionogi Submits S-877503 NDA For ADHD In Japan
Industry Brief - CHMP Adopts Positive Opinion On Abilify Maintena Label Update
Industry Brief - FDA Accepts Rexulti sNDA For Review In Maintenance Treatment Of Schizophrenia
Industry Brief - Alkermes Initiates Second Phase III Study Of ALKS 3831 In Schizophrenia
Industry Trend Analysis - Intuniv Sales Focus Will Remain On Non-US Markets
Industry Trend Analysis - Invalid Patent Ruling Will Allow Abuse Deterrence Alternatives
Industry Brief - Teligent Gains Lidocaine Approval
Industry Brief - Collegium Granted US Patent Covering DETERx Technology Platform
Industry Brief - Depomed Gains Favourable Markman Ruling In Tapentadol Litigation
Industry Brief - Eisai/Esteve Sign Fycompa Co-Promotion Deal In Spain
Industry Trend Analysis - 2016 Will Be Pivotal For GW Pharmaceuticals
Industry Trend Analysis - Expanded Injectable Approval Will Not Maintain Emend's Market Position
Industry Brief - Neurocrine Initiates Phase II Study of VMAT2 Inhibitor Valbenazine
Industry Brief - Asterias' AST-OPC1 Gains FDA ODD For Acute SCI
Industry Trend Analysis - Controversial Opioid Induced Constipation Ad Will Drive Opioid Debate
Industry Brief - Pozen/Tribute Merger Completed
Industry Trend Analysis - External Sourcing Remains UCB's Focus For CNS Pipeline
Industry Brief - Yumanity Therapeutics Completes Fundraising
Industry Trend Analysis - Strong FY15 Growth Will Support Shire's Shifting Focus
Industry Brief - CNS Conferences - May 2016

Table Of Contents

CNS Drug News 15 FEBRUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorde ...

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by GlobalData

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorder is characterized ...

Schizophrenia - US Drug Forecast and Market Analysis to 2025

Schizophrenia - US Drug Forecast and Market Analysis to 2025

  • $ 4995
  • Industry report
  • November 2016
  • by GlobalData

Schizophrenia - US Drug Forecast and Market Analysis to 2025 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorder is characterized ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.